Literature DB >> 16841035

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

Ellen R M de Haas1, Bastiaan Kruijt, Henricus J C M Sterenborg, H A Martino Neumann, Dominic J Robinson.   

Abstract

Photodynamic therapy (PDT) of superficial basal cell carcinoma (sBCC) using topical 5-aminolevulinic acid (ALA) and a light fluence of 75-100 J cm(-2) yields unsatisfactory long-term results. In several animal models, illumination with two light fractions 2 hours apart was considerably more effective than single illumination. Response is further enhanced if the fluence of the first light fraction is reduced, although the cumulative fluence is maintained. We compared the response of sBCC to a single illumination and 2-fold illumination scheme in which two light fractions of 20 and 80 J cm(-2) are performed 4 and 6 hours after the application of a single dose of 20% ALA. We randomly assigned 154 patients with a total of 505 primary sBCC into two treatment groups. Two hundred and forty-three lesions were treated using a single illumination of 75 J cm(-2) at a fluence rate of 50 mW cm(-2). Fractionated PDT, at the same fluence rate, was performed on 262 lesions. The complete response (CR) following a 2-fold illumination scheme is significantly greater than that following a single light fraction (P=0.002, log-rank test). Twelve months after therapy, CR rate to a 2-fold illumination is 97%, whereas the CR to a single illumination is 89%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841035     DOI: 10.1038/sj.jid.5700460

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

Review 1.  Photodynamic therapy in dermatology: a review.

Authors:  Sonal Choudhary; Keyvan Nouri; Mohamed L Elsaie
Journal:  Lasers Med Sci       Date:  2009-08-05       Impact factor: 3.161

Review 2.  Basal cell carcinoma.

Authors:  Anthony Ormerod; Sanjay Rajpara; Fiona Craig
Journal:  BMJ Clin Evid       Date:  2010-04-06

3.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.

Authors:  Kishore R Rollakanti; Stephen C Kanick; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photonics Lasers Med       Date:  2013-11-01

4.  An insight into photodynamic therapy towards treating major dermatological conditions.

Authors:  Anuradha Dey; Gautam Singhvi; Anu Puri; Prashant Kesharwani; Sunil Kumar Dubey
Journal:  J Drug Deliv Sci Technol       Date:  2022-08-30       Impact factor: 5.062

5.  Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines.

Authors:  Jiabin Yang; Yumin Xia; Xiaoming Liu; Shan Jiang; Layuan Xiong
Journal:  Lasers Med Sci       Date:  2009-08-25       Impact factor: 3.161

6.  Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.

Authors:  William J Cottrell; Anne D Paquette; Kenneth R Keymel; Thomas H Foster; Allan R Oseroff
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

7.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

8.  Review of photodynamic therapy in actinic keratosis and basal cell carcinoma.

Authors:  Marica B Ericson; Ann-Marie Wennberg; Olle Larkö
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

9.  Interventions for basal cell carcinoma of the skin.

Authors:  Jason Thomson; Sarah Hogan; Jo Leonardi-Bee; Hywel C Williams; Fiona J Bath-Hextall
Journal:  Cochrane Database Syst Rev       Date:  2020-11-17

10.  Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.

Authors:  Ana Luiza Ribeiro de Souza; Kayla Marra; Jason Gunn; Kimberley S Samkoe; Stephen Chad Kanick; Scott C Davis; M Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Br J Cancer       Date:  2016-08-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.